# A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen

> **NCT01497470** · PHASE1 · COMPLETED · sponsor: **Achieve Life Sciences** · enrollment: 36 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Custirsen, paclitaxel and carboplatin

## Key facts

- **NCT ID:** NCT01497470
- **Lead sponsor:** Achieve Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-07
- **Final completion:** 2013-10
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2016-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01497470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01497470, "A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01497470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*